These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Experimental and clinical pharmacology of carvedilol and other drugs combining vasodilation and beta-adrenoceptor antagonism in a single molecule. Strein K, Sponer G. Z Kardiol; 1990 Nov; 79 Suppl 3():89-98. PubMed ID: 1983054 [Abstract] [Full Text] [Related]
23. Can intravenous beta-blockade predict long-term hemodynamic benefit in chronic congestive heart failure secondary to ischemic heart disease? A comparison of intravenous with oral carvedilol. DasGupta P, Lahiri A. J Cardiovasc Pharmacol; 1992 Nov; 19 Suppl 1():S62-7. PubMed ID: 1378153 [Abstract] [Full Text] [Related]
24. Antianginal efficacy of carvedilol, a new beta-blocker with vasodilating action. Jamal SM, Freedman SB, Thomson A, Carter G, Harris PJ, Kelly DT. J Cardiovasc Pharmacol; 1987 Nov; 10 Suppl 11():S141-6. PubMed ID: 2454361 [Abstract] [Full Text] [Related]
25. Hemodynamic effects of carvedilol after acute oral administration in hypertensive and normal subjects. Cournot A, Lim C, Duchier J, Safar M. J Cardiovasc Pharmacol; 1992 Nov; 19 Suppl 1():S35-9. PubMed ID: 1378147 [Abstract] [Full Text] [Related]
29. Effects of carvedilol on left ventricular function and arrhythmias during repeated short-time myocardial ischemia in experimental pigs. Höher M, Friedrich M, Sommer T, Marten A, Ehmer B, Hombach V, Hirche H. Z Kardiol; 1989 Nov; 78 Suppl 3():7-15. PubMed ID: 2573214 [Abstract] [Full Text] [Related]
37. Effects of the alpha-/beta-blocking agent carvedilol on hepatic and systemic hemodynamics in patients with cirrhosis and portal hypertension. Sekiyama T, Komeichi H, Nagano T, Ohsuga M, Terada H, Katsuta Y, Satomura K, Aramaki T. Arzneimittelforschung; 1997 Apr; 47(4):353-5. PubMed ID: 9150854 [Abstract] [Full Text] [Related]